中国缺血性卒中及短暂性脑缺血发作患者 血脂长期管理科学声明.

The disease burden is substantial among Chinese patients with ischemic stroke (IS) and TIA. High LDL-C level is an independent risk factor for stroke recurrence. It is of clinical significance to assess the reasons resulting in unfavorable LDL-C control in patients, develop further treatment strategies, monitor frequencies to improve the LDL-C target attainment rate. To strengthen the understanding of medical workers on the long-term management and monitoring of IS and TIA, and standardize clinical practice of long-term lipid management, this scientific statement was formulated by clinical experts in cerebrovascular disease organized by the Chinese Stroke Association’s Subcommittee on Medical Quality Management and Promotion. The scientific statement, based on evidence-based research, clinical practice, multiple rounds of expert opinion collection, and thorough discussions, elaborated on long-term lipid management, monitoring, and lipid management in high-risk patients in IS and TIA. It aims to provide reference for improving clinical in long-term lipid management for IS and TIA patients. [ABSTRACT FROM AUTHOR]